Chimaeric site-specific recombinases for 'genomic surgery'
Chimaeric site-specific recombinases for 'genomic surgery'
批准号:
BB/F021593/1
负责人:
Marshall Stark
金额:
$44.55万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
All living organisms contain immensely long double-helical DNA molecules that carry the information each cell needs to grow and multiply. This information is encoded in the sequence of the DNA building blocks called bases, strings of which encode messages known as genes. Cellular machines translate the code into useful molecules such as proteins. Sometimes we would like to 'edit' the DNA code; for example, by deleting a 'bad' gene that causes a disease, or by inserting a new gene that cures a disease or that makes an organism produce a useful substance such as an antibody. We are trying to develop tools for doing this DNA editing or 'genomic surgery', by modifying a class of natural proteins called site-specific recombinases which can already do reactions like this in bacteria. However, the bacterial enzymes only work at bacterial DNA sequences that they have evolved to recognize. In order to make them more generally useful, we must find a way of converting them so that they can recognize and 'cut and paste' at any DNA sequences that we choose. We have already demonstrated that one type of site-specific recombinase called resolvase can be modified so that it will act at a new sequence. To do this we replace the part of the resolvase protein that is designed to recognize the sequence of DNA bases with a DNA-recognizing module from another protein called Zif268. We call this hybrid protein a Z-resolvase. The Zif268 module is used because other research groups have worked out how to change it so that it can recognize almost any chosen DNA sequence of about 9 bases. We can therefore potentially make Z-resolvases that can be placed on any DNA target using their attached Zif268 module. However, there is still a lot to do before Z-resolvases can be used for very demanding applications, like curing human diseases, where any editing of the wrong DNA sequences could be disastrous. In this project, we want to develop Z-resolvases so that they work on almost any chosen DNA sequence with the efficiency and precision necessary for real uses in biotechnology and gene therapy. To reach this goal we will have to optimize the properties of Z-resolvase. We need to modify the part of Z-resolvase that actually breaks and rejoins DNA strands, so that it can deal with any DNA sequence that it is placed on. We must ensure that our Z-resolvase proteins are very specific for the chosen sequence, and do not damage the DNA elsewhere. We want to be able to control the type of changes in the DNA that a Z-resolvase brings about; for example, to make sure that it cuts a section out and does not put it back in. Finally, we must make sure that Z-resolvases work efficiently in humans and other species where they might be used. To test whether we have achieved these objectives, we aim to demonstrate that we can use Z-resolvases to cut out the piece of DNA encoding HIV (the virus that causes AIDS in humans) from a cell's DNA, thus preventing it from making more virus copies.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0019537
发表时间:
2011-04-29
期刊:
PloS one
影响因子:
3.7
作者:
[Proudfoot C, McPherson AL, Kolb AF, Stark WM]
通讯作者:
Stark WM
DOI:
10.1128/9781555817954
发表时间:
2002
期刊:
影响因子:
--
作者:
[N. Craig;M. Chandler;M. Gellert;A. Lambowitz;P. Rice;S. Sandmeyer]
通讯作者:
N. Craig;M. Chandler;M. Gellert;A. Lambowitz;P. Rice;S. Sandmeyer
DOI:
10.1093/nar/gkr652
发表时间:
2011-11
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Prorocic MM, Wenlong D, Olorunniji FJ, Akopian A, Schloetel JG, Hannigan A, McPherson AL, Stark WM]
通讯作者:
Stark WM
Elucidation of the rotary mechanism of serine recombinases
-
批准号:BB/R008493/1
-
项目类别:Research Grant
-
资助金额:$60.24万
-
财政年份:2018
-
负责人:Marshall Stark
-
依托单位:
A platform for rapid and precise DNA module rearrangements in Synthetic Biology
-
批准号:BB/K003356/1
-
项目类别:Research Grant
-
资助金额:$416.07万
-
财政年份:2013
-
负责人:Marshall Stark
-
依托单位:
The mechanism of DNA strand exchange by serine recombinases
-
批准号:BB/E022200/1
-
项目类别:Research Grant
-
资助金额:$48.63万
-
财政年份:2007
-
负责人:Marshall Stark
-
依托单位:
国内基金
海外基金
登录
查看更多内容
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
-
批准号:82370790
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶蕾
-
依托单位:
具有共形结构的高性能Ta4SiTe4基有机/无机复合柔性热电薄膜
-
批准号:52172255
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:瞿三寅
-
依托单位:
棕色脂肪细胞脂滴与线粒体锚定的功能与机制研究
-
批准号:32100557
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:崔留娟
-
依托单位:
新型WDR5蛋白Win site抑制剂的合理设计、合成及其抗肿瘤活性研究
-
批准号:82103981
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:陈维琳
-
依托单位:
肝细胞线粒体-脂滴互作的分子机制研究
-
批准号:32100536
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周茂阁
-
依托单位:
内质网、线粒体、细胞核互作网络与钙离子调控机制研究
-
批准号:92054105
-
项目类别:重大研究计划
-
资助金额:80.0万元
-
批准年份:2020
-
负责人:贺号
-
依托单位:
基于p32-GCS1复合物的线粒体-内质网互作体系鉴定与功能研究
-
批准号:92054106
-
项目类别:重大研究计划
-
资助金额:83.0万元
-
批准年份:2020
-
负责人:刘泳
-
依托单位:
黄病毒组装促进内质网-脂滴互作的调控机制研究
-
批准号:92054104
-
项目类别:重大研究计划
-
资助金额:83.0万元
-
批准年份:2020
-
负责人:酒亚明
-
依托单位:
PKM2调控脂滴与线粒体互作机制及生理功能研究
-
批准号:92054107
-
项目类别:重大研究计划
-
资助金额:83.0万元
-
批准年份:2020
-
负责人:丁彬彬
-
依托单位: